Refreshing results…
Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations
Download from doi.orgNeratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
UploadMissing publications? Search for publications with a matching author name.